In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) closed at $2.64 in the last session, up 6.02% from day before closing price of $2.49. In other words, the price has increased by $6.02 from its previous closing price. On the day, 0.57 million shares were traded. NRXP stock price reached its highest trading level at $2.74 during the session, while it also had its lowest trading level at $2.455.
Ratios:
We take a closer look at NRXP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.11 and its Current Ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on September 08, 2025, initiated with a Buy rating and assigned the stock a target price of $40.
On April 02, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $18.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Javitt Jonathan C bought 40,000 shares for $1.17 per share. The transaction valued at 46,800 led to the insider holds 84,634 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 62752540 and an Enterprise Value of 58965404.
Stock Price History:
The Beta on a monthly basis for NRXP is 1.92, which has changed by 1.1465516 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, NRXP has reached a high of $6.01, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -12.69%, while the 200-Day Moving Average is calculated to be -1.86%.
Shares Statistics:
According to the various share statistics, NRXP traded on average about 466.57K shares per day over the past 3-months and 452800 shares per day over the past 10 days. A total of 23.77M shares are outstanding, with a floating share count of 21.02M. Insiders hold about 11.55% of the company’s shares, while institutions hold 26.17% stake in the company. Shares short for NRXP as of 1761868800 were 860796 with a Short Ratio of 1.84, compared to 1759190400 on 759569. Therefore, it implies a Short% of Shares Outstanding of 860796 and a Short% of Float of 3.92.
Earnings Estimates
The dynamic stock of NRX Pharmaceuticals Inc (NRXP) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.06, with high estimates of $0.21 and low estimates of -$0.06.
Analysts are recommending an EPS of between $0.15 and -$1.33 for the fiscal current year, implying an average EPS of -$0.58. EPS for the following year is $0.34, with 2.0 analysts recommending between $0.42 and $0.25.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $10.25M. There is a high estimate of $16.5M for the next quarter, whereas the lowest estimate is $1M.
Based on 4 analysts’ estimates, the company’s revenue will be $129.09M in the next fiscal year. The high estimate is $241.4M and the low estimate is $42.57M.
